LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.0053333
29.92 84.90 1896 2237 0.8473 0.9310
MN20160318_Q02
D17
MCF 10A-H2B-mCherry Neratinib
0.0053333
29.92 84.90 209 2237 0.0934 0.2103
MN20160318_Q02
I21
MCF 10A-H2B-mCherry Neratinib
0.0053333
29.92 84.90 2709 2237 1.2106 1.0826
MN20160318_Q02
I21
MCF 10A-H2B-mCherry Neratinib
0.0053333
31.62 84.90 97 2449 0.0396 0.0279
MN20160318_Q02
D17
MCF 10A-H2B-mCherry Neratinib
0.0053333
31.62 84.90 2119 2449 0.8650 0.9411
MN20160318_Q02
D17
MCF 10A-H2B-mCherry Neratinib
0.0053333
31.62 84.90 235 2449 0.0959 0.2336
MN20160318_Q02
I21
MCF 10A-H2B-mCherry Neratinib
0.0053333
31.62 84.90 2936 2449 1.1985 1.0761
MN20160318_Q02
I21
MCF 10A-H2B-mCherry Neratinib
0.0053333
33.32 84.90 107 2722 0.0393 0.0473
MN20160318_Q02
D17
MCF 10A-H2B-mCherry Neratinib
0.0053333
33.32 84.90 2293 2722 0.8423 0.9325
MN20160318_Q02
D17
MCF 10A-H2B-mCherry Neratinib
0.0053333
33.32 84.90 285 2722 0.1047 0.2739
MN20160318_Q02
I21
MCF 10A-H2B-mCherry Neratinib
0.0053333
33.32 84.90 3225 2722 1.1846 1.0689
MN20160318_Q02
I21
MCF 10A-H2B-mCherry Neratinib
0.0053333
35.03 84.90 132 2991 0.0441 0.0897
MN20160318_Q02
D17
MCF 10A-H2B-mCherry Neratinib
0.0053333
35.03 84.90 2475 2991 0.8274 0.9276
MN20160318_Q02
D17
MCF 10A-H2B-mCherry Neratinib
0.0053333
35.03 84.90 343 2991 0.1147 0.3122
MN20160318_Q02
I21
MCF 10A-H2B-mCherry Neratinib
0.0053333
35.03 84.90 3525 2991 1.1784 1.0649
MN20160318_Q02
I21
MCF 10A-H2B-mCherry Neratinib
0.0053333
36.73 84.90 136 3254 0.0418 0.0937
MN20160318_Q02
D17
MCF 10A-H2B-mCherry Neratinib
0.0053333
36.73 84.90 2651 3254 0.8146 0.9235
MN20160318_Q02
D17
MCF 10A-H2B-mCherry Neratinib
0.0053333
36.73 84.90 383 3254 0.1177 0.3316
MN20160318_Q02
I21
MCF 10A-H2B-mCherry Neratinib
0.0053333
36.73 84.90 3759 3254 1.1551 1.0556
MN20160318_Q02
I21
MCF 10A-H2B-mCherry Neratinib
0.0053333
38.43 84.90 189 3459 0.0546 0.1614
MN20160318_Q02
D17
MCF 10A-H2B-mCherry Neratinib
0.0053333
38.43 84.90 2893 3459 0.8362 0.9342
MN20160318_Q02
D17
MCF 10A-H2B-mCherry Neratinib
0.0053333
38.43 84.90 393 3459 0.1136 0.3318
MN20160318_Q02
I21
MCF 10A-H2B-mCherry Neratinib
0.0053333
38.43 84.90 4023 3459 1.1628 1.0572
MN20160318_Q02
I21
MCF 10A-H2B-mCherry Neratinib
0.0053333
40.14 84.90 220 3682 0.0597 0.1913
MN20160318_Q02
D17
MCF 10A-H2B-mCherry Neratinib
0.0053333
40.14 84.90 3116 3682 0.8463 0.9396
MN20160318_Q02
D17